Overview

This trial is active, not recruiting.

Conditions blood safety, blood transfusion
Sponsor Universitaire Ziekenhuizen Leuven
Start date July 2015
End date May 2017
Trial size 7835 participants
Trial identifier NCT02513966, s58228

Summary

There is a decrease in the amount of blood components used during cardiac surgery in the last four years. As the hemovigilance team of the investigators' Hospital the investigators want to find out the causes and effects of this decrease.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective retrospective

Primary Outcomes

Measure
amount of blood use during Cardiac surgery
time frame: 5years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - patient underwent cardiac surgery between 2010 and 2014 in UZ Leuven Exclusion Criteria: - patient without cardiac surgery

Additional Information

Official title Decreased Consumption of Blood Components During Cardiac Surgery Procedures: Causes and Effects.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Universitaire Ziekenhuizen Leuven.